HS Code 3004.90 : Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other
MODULE 2: EXTRACTABLE ANSWER (AEO / SPEAKABLE)
Tariff data verified: July 2026
EN (Official WCO)
FR (Pending)
ES (Pending)
The 6-digit Harmonized System (HS) code for medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, other is 3004.90. Under the 2026 United States (USITC HTS), the representative MFN general duty rate is Free [USITC HTS Tariff Schedule 2026].
MODULE 3: SIGNATURE A: HS DECODE VISUAL HIERARCHY
Chapter 30
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
Heading 3004
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
Subheading .90
.90
Other
MODULE 4: SIGNATURE B: TARIFF MATRIX
Import Duty Rates by Destination
United StatesUnited KingdomEuropean UnionCanadaMexicoChinaJapanIndiaAustraliaSouth KoreaGermanyNetherlandsBrazilTürkiyeChinese TaipeiVietnamThailandIndonesiaMalaysiaSingaporeSaudi ArabiaUnited Arab EmiratesSouth AfricaEgyptIsraelChileColombiaPeruPhilippinesPakistanNew ZealandNorwayNigeriaKenyaMoroccoArgentinaEcuadorBangladeshUkraineKazakhstanQatarKuwaitOmanJordanBahrainSri LankaTunisiaGhanaCôte d'IvoireGeorgiaCambodiaPanamaCosta RicaDominican Republic
United States (USITC HTS 2026)
3004.90
MODULE 5: US IMPORT DUTY & FEE BREAKDOWN (LANDED COST STACK)
Federal Import VAT / GST
0.00%
US Has NO Federal VAT
Notice: Duty rates and trade remedies change frequently (Section 301, Section 232, anti-dumping orders, de minimis thresholds). Duty calculations are estimates for informational purposes only. Always verify exact rates with U.S. Customs and Border Protection (CBP) or a licensed customs broker prior to import.
TRACK THIS HS CODE
Get Real-Time Tariff & Trade Remedy Change Alerts for HS 3004.90
Receive an automated email notification whenever USITC or CBP publishes duty rate adjustments or customs notices for 3004.90.
MODULE 6: Mandatory Customs Entry Document Matrix
Rule-Derived Customs Entry Package Checklist
UNIVERSAL DOCUMENT
Commercial Invoice
Itemized description, currency, Incoterms, seller/buyer details, and country of origin.
UNIVERSAL DOCUMENT
Packing List & Bill of Lading
Gross/net weight, container/seal numbers, piece count, and transport B/L or Air Waybill.
AGENCY-CONDITIONAL (PGA)
FDA Prior Notice / USDA Phytosanitary Cert
Rule-derived from verified PGA flag: Mandatory prior notice filing and health certificate.
MODULE 7: Regulatory Compliance & Partner Government Agency (PGA) Flags
ACE PGA Message-Set Flags:
FDA (DRU): FDA Drug Establishment Registration & National Drug Code (NDC)
Official ACE program code: ACE/PGA [FDA 21 CFR 1.276].
MODULE 8: Trade Remedies (Section 301, Section 232, AD/CVD)
China Section 301 Tariff Status
0% Additional Duty (Exempt)
Section 232 Steel/Aluminum Status
Exempt (Non-Metal Commodity)
EU CBAM Carbon Alert
Not in Scope
MODULE 9: Free Trade Agreements (FTA) & Rules of Origin (RoO)
Browse all preferential trade calculators & compliance tools in our Customs Tools Hub ↗.
| Agreement Code | Trade Agreement / Program | Preferential Rate | Rules of Origin (RoO) Requirement |
|---|---|---|---|
| P | United States-Mexico-Canada Agreement (USMCA) | Free | Must meet USMCA Regional Value Content (RVC) or tariff shift rules. |
| KR | U.S.-Korea Free Trade Agreement (KORUS) | Free | Direct shipment from South Korea with KORUS Certificate of Origin. |
| AU | U.S.-Australia Free Trade Agreement | Free | Wholly obtained or tariff shift rule under US-Australia FTA. |
| A / D | GSP / African Growth & Opportunity Act (AGOA) | Free | 35% local value-add requirement for beneficiary country origin. |
MODULE 10: Logistics, Freight & Transport Specifications
Standard 20ft Container
~28 CBM / 28,000 kg Payload
Standard 40ft High-Cube
~68 CBM / 28,600 kg Payload
Stowage Factor & Handling
Standard commercial packaging for Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other
MODULE 11: Official CBP CROSS Binding Classification Rulings
| Ruling # | Subject / Product Description | HTS Code | Ruling Date | Precedent Link |
|---|---|---|---|---|
| K87058 | The tariff classification of children’s aspirin tablets, enteric-coated aspirin tablets, and calcium carbonate antacid tablets from China | 3004.90.9128 | 2004-06-21 | View Precedent K87058 → |
| N297980 | The tariff classification of Aspirin and ER Dipyridamole Capsules and Labetalol Hydrochloride Tablets in dosage form, from India | 3004.90.9220 | 2018-07-11 | View Precedent N297980 → |
| N304734 | The tariff classification of Aspirin and Extended-Release Dipyridamole Capsules in dosage form, from India | 3004.90.9220 | 2019-07-01 | View Precedent N304734 → |
| H88019 | The tariff classification of Azathioprine tablets from Germany, India, and the United Kingdom | 3004.90.9115 | 2002-02-14 | View Precedent H88019 → |
| M82455 | The tariff classification of Azathioprine Tablets, Haloperidol Tablets, and Paroxetine Tablets from India | 3004.90.9115 | 2006-04-24 | View Precedent M82455 → |
| C83486 | The tariff classification of Herp-ezy Lip Balm from England | 3004.90.9090 | 1998-01-22 | View Precedent C83486 → |
US National HTS Tariff Lines (3004.90)
| HTS Code | Description | General Rate | Special (FTA) Rate | Column 2 Rate | Unit |
|---|---|---|---|---|---|
| 3004.90 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other | Free | Free | Rate on request | — |
| 3004.90.10.00 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing antigens or hyaluronic acid or its sodium salt | Free | Free | Free | kg |
| 3004.90.92 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other | Free | Free | 30% | — |
| 3004.90.92.01 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, For veterinary use | Free | Free | Rate on request | kg |
| 3004.90.92.03 | Other, Other, Other, Anti-infective medicaments, Antivirals, Containing acyclovir or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.04 | Other, Other, Other, Anti-infective medicaments, Antivirals, Containing oseltamivir or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.05 | Other, Other, Other, Anti-infective medicaments, Antivirals, Containing valganciclovir, peramivir or their salts | Free | Free | Rate on request | kg |
| 3004.90.92.06 | Other, Other, Other, Anti-infective medicaments, Antivirals, Other | Free | Free | Rate on request | kg |
| 3004.90.92.07 | Other, Other, Other, Anti-infective medicaments, Antifungals, Containing fluconazole or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.08 | Other, Other, Other, Anti-infective medicaments, Antifungals, Other | Free | Free | Rate on request | kg |
| 3004.90.92.09 | Other, Other, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Containing metronidazole or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.10 | Other, Other, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Other | Free | Free | Rate on request | kg |
| 3004.90.92.11 | Other, Other, Other, Anti-infective medicaments, Sulfonamides, Containing trimethoprim and sulfamethoxazole or their salts | Free | Free | Rate on request | kg |
| 3004.90.92.12 | Other, Other, Other, Anti-infective medicaments, Sulfonamides, Other | Free | Free | Rate on request | kg |
| 3004.90.92.13 | Other, Other, Other, Anti-infective medicaments, Other, Containing levofloxacin or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.14 | Other, Other, Other, Anti-infective medicaments, Other, Containing linezolid or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.15 | Other, Other, Other, Anti-infective medicaments, Other, Other | Free | Free | Rate on request | kg |
| 3004.90.92.16 | Other, Other, Other, Antineoplastic and immunosuppressive medicaments, Containing hydroxyurea or cyclophosphamide or their salts | Free | Free | Rate on request | kg |
| 3004.90.92.17 | Other, Other, Other, Antineoplastic and immunosuppressive medicaments, Containing tacrolimus or mycophenolate mofetil or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.18 | Other, Other, Other, Antineoplastic and immunosuppressive medicaments, Other | Free | Free | Rate on request | kg |
| 3004.90.92.19 | Other, Other, Other, Cardiovascular medicaments, Containing metoprolol or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.20 | Other, Other, Other, Cardiovascular medicaments, Containing amiodarone or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.21 | Other, Other, Other, Cardiovascular medicaments, Containing diltiazem or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.22 | Other, Other, Other, Cardiovascular medicaments, Containing hydralazine or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.23 | Other, Other, Other, Cardiovascular medicaments, Containing enoxaparin or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.24 | Other, Other, Other, Cardiovascular medicaments, Containing labetalol or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.25 | Other, Other, Other, Cardiovascular medicaments, Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts | Free | Free | Rate on request | kg |
| 3004.90.92.26 | Other, Other, Other, Cardiovascular medicaments, Other | Free | Free | Rate on request | kg |
| 3004.90.92.27 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin | Free | Free | Rate on request | kg |
| 3004.90.92.28 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium dihydrate | Free | Free | Rate on request | kg |
| 3004.90.92.29 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium (anhydrous) | Free | Free | Rate on request | kg |
| 3004.90.92.30 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, For oral suspension | Free | Free | Rate on request | kg |
| 3004.90.92.31 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, Other | Free | Free | Rate on request | kg |
| 3004.90.92.32 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, For oral suspension | Free | Free | Rate on request | kg |
| 3004.90.92.33 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, Other | Free | Free | Rate on request | kg |
| 3004.90.92.34 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing O-Acetylsalicylic acid (Aspirin) | Free | Free | Rate on request | kg |
| 3004.90.92.35 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing tramadol | Free | Free | Rate on request | kg |
| 3004.90.92.36 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Other | Free | Free | Rate on request | kg |
| 3004.90.92.37 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing dexmedetomidine, etomidate, midazolam, propofol or their salts | Free | Free | Rate on request | kg |
| 3004.90.92.38 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing midazolam or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.39 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing phenytoin or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.40 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing propofol or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.41 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing levetiracetam, phenytoin or their salts | Free | Free | Rate on request | kg |
| 3004.90.92.42 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing etomidate or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.43 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Other | Free | Free | Rate on request | kg |
| 3004.90.92.44 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing lorazepam or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.45 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing olanzapine or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.46 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Other | Free | Free | Rate on request | kg |
| 3004.90.92.47 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Other, Containing rocuronium or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.48 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Other, Containing succinylcholine or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.49 | Other, Other, Other, Medicaments primarily affecting the central nervous system, Other, Other | Free | Free | Rate on request | kg |
| 3004.90.92.50 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Dermatological agents and local anesthetics, Containing lidocaine or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.51 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Dermatological agents and local anesthetics, Other | Free | Free | Rate on request | kg |
| 3004.90.92.52 | Other, Other, Other, Medicaments primarily affecting the digestive system, Laxatives | Free | Free | Rate on request | kg |
| 3004.90.92.53 | Other, Other, Other, Medicaments primarily affecting the digestive system, Antacids | Free | Free | Rate on request | kg |
| 3004.90.92.54 | Other, Other, Other, Medicaments primarily affecting the digestive system, Containing famotidine or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.55 | Other, Other, Other, Medicaments primarily affecting the digestive system, Containing pantoprazole or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.56 | Other, Other, Other, Medicaments primarily affecting the digestive system, Containing ondansetron or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.57 | Other, Other, Other, Medicaments primarily affecting the digestive system, Containing glycopyrrolate or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.58 | Other, Other, Other, Medicaments primarily affecting the digestive system, Containing loperamide or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.60 | Other, Other, Other, Medicaments primarily affecting the digestive system, Other | Free | Free | Rate on request | kg |
| 3004.90.92.61 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing furosemide and its salts | Free | Free | Rate on request | kg |
| 3004.90.92.62 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing hydrochlorothiazide or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.63 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Other | Free | Free | Rate on request | kg |
| 3004.90.92.64 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing calcium gluconate | Free | Free | Rate on request | kg |
| 3004.90.92.65 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing potassium chloride | Free | Free | Rate on request | kg |
| 3004.90.92.66 | Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing sodium bicarbonate, in injection form | Free | Free | Rate on request | kg |
| 3004.90.92.67 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Other | Free | Free | Rate on request | kg |
| 3004.90.92.68 | Other, Other, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Cough and cold preparations | Free | Free | Rate on request | kg |
| 3004.90.92.69 | Other, Other, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Containing diphenhydramine or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.70 | Other, Other, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Other | Free | Free | Rate on request | kg |
| 3004.90.92.71 | Other, Other, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing albuterol sulfate | Free | Free | Rate on request | kg |
| 3004.90.92.72 | Other, Other, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Other, Containing timolol maleate | Free | Free | Rate on request | kg |
| 3004.90.92.73 | Other, Other, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Other, Other | Free | Free | Rate on request | kg |
| 3004.90.92.74 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Other, Containing heparin sodium or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.75 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Other, Containing zoledronic acid or its salts | Free | Free | Rate on request | kg |
| 3004.90.92.76 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Other, Other, Other, Other | Free | Free | Rate on request | kg |
US 10-Digit Statistical HTS Breakout (3004.90)
75 Declarable Lines · USITC 2026| 10-Digit HTS Code | Statistical Description | General MFN Rate | FTA / Special Rate | Unit |
|---|---|---|---|---|
| 3004.90.10.00 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Containing antigens or hyaluronic acid or its sodium salt | Free | Base MFN | kg |
| 3004.90.92.01 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other For veterinary use | Free | Base MFN | kg |
| 3004.90.92.03 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antivirals: Containing acyclovir or its salts | Free | Base MFN | kg |
| 3004.90.92.04 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antivirals: Containing oseltamivir or its salts | Free | Base MFN | kg |
| 3004.90.92.05 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antivirals: Containing valganciclovir, peramivir or their salts | Free | Base MFN | kg |
| 3004.90.92.06 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antivirals: Other | Free | Base MFN | kg |
| 3004.90.92.07 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antifungals: Containing fluconazole or its salts | Free | Base MFN | kg |
| 3004.90.92.08 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antifungals: Other | Free | Base MFN | kg |
| 3004.90.92.09 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antiprotozoals (excluding goods described in subheading note 2 to this chapter): Containing metronidazole or its salts | Free | Base MFN | kg |
| 3004.90.92.10 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Antiprotozoals (excluding goods described in subheading note 2 to this chapter): Other | Free | Base MFN | kg |
| 3004.90.92.11 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Sulfonamides: Containing trimethoprim and sulfamethoxazole or their salts | Free | Base MFN | kg |
| 3004.90.92.12 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Sulfonamides: Other | Free | Base MFN | kg |
| 3004.90.92.13 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Other: Containing levofloxacin or its salts | Free | Base MFN | kg |
| 3004.90.92.14 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Other: Containing linezolid or its salts | Free | Base MFN | kg |
| 3004.90.92.15 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Anti-infective medicaments: Other: Other | Free | Base MFN | kg |
| 3004.90.92.16 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Antineoplastic and immunosuppressive medicaments: Containing hydroxyurea or cyclophosphamide or their salts | Free | Base MFN | kg |
| 3004.90.92.17 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Antineoplastic and immunosuppressive medicaments: Containing tacrolimus or mycophenolate mofetil or its salts | Free | Base MFN | kg |
| 3004.90.92.18 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Antineoplastic and immunosuppressive medicaments: Other | Free | Base MFN | kg |
| 3004.90.92.19 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing metoprolol or its salts | Free | Base MFN | kg |
| 3004.90.92.20 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing amiodarone or its salts | Free | Base MFN | kg |
| 3004.90.92.21 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing diltiazem or its salts | Free | Base MFN | kg |
| 3004.90.92.22 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing hydralazine or its salts | Free | Base MFN | kg |
| 3004.90.92.23 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing enoxaparin or its salts | Free | Base MFN | kg |
| 3004.90.92.24 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing labetalol or its salts | Free | Base MFN | kg |
| 3004.90.92.25 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts | Free | Base MFN | kg |
| 3004.90.92.26 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Cardiovascular medicaments: Other | Free | Base MFN | kg |
| 3004.90.92.27 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Tolmetin | Free | Base MFN | kg |
| 3004.90.92.28 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Tolmetin sodium dihydrate | Free | Base MFN | kg |
| 3004.90.92.29 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Tolmetin sodium (anhydrous) | Free | Base MFN | kg |
| 3004.90.92.30 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Containing ibuprofen or its salts: For oral suspension | Free | Base MFN | kg |
| 3004.90.92.31 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Containing ibuprofen or its salts: Other | Free | Base MFN | kg |
| 3004.90.92.32 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Containing acetaminophen or its salts: For oral suspension | Free | Base MFN | kg |
| 3004.90.92.33 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Containing acetaminophen or its salts: Other | Free | Base MFN | kg |
| 3004.90.92.34 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Containing O-Acetylsalicylic acid (Aspirin) | Free | Base MFN | kg |
| 3004.90.92.35 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Containing tramadol | Free | Base MFN | kg |
| 3004.90.92.36 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Analgesics, antipyretics and nonhormonal anti-inflammatory agents: Other | Free | Base MFN | kg |
| 3004.90.92.37 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Containing dexmedetomidine, etomidate, midazolam, propofol or their salts | Free | Base MFN | kg |
| 3004.90.92.38 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Containing midazolam or its salts | Free | Base MFN | kg |
| 3004.90.92.39 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Containing phenytoin or its salts | Free | Base MFN | kg |
| 3004.90.92.40 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Containing propofol or its salts | Free | Base MFN | kg |
| 3004.90.92.41 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Containing levetiracetam, phenytoin or their salts | Free | Base MFN | kg |
| 3004.90.92.42 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Containing etomidate or its salts | Free | Base MFN | kg |
| 3004.90.92.43 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives: Other | Free | Base MFN | kg |
| 3004.90.92.44 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents: Containing lorazepam or its salts | Free | Base MFN | kg |
| 3004.90.92.45 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents: Containing olanzapine or its salts | Free | Base MFN | kg |
| 3004.90.92.46 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents: Other | Free | Base MFN | kg |
| 3004.90.92.47 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Other: Containing rocuronium or its salts | Free | Base MFN | kg |
| 3004.90.92.48 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Other: Containing succinylcholine or its salts | Free | Base MFN | kg |
| 3004.90.92.49 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the central nervous system: Other: Other | Free | Base MFN | kg |
| 3004.90.92.50 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Dermatological agents and local anesthetics: Containing lidocaine or its salts | Free | Base MFN | kg |
| 3004.90.92.51 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Dermatological agents and local anesthetics: Other | Free | Base MFN | kg |
| 3004.90.92.52 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Laxatives | Free | Base MFN | kg |
| 3004.90.92.53 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Antacids | Free | Base MFN | kg |
| 3004.90.92.54 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Containing famotidine or its salts | Free | Base MFN | kg |
| 3004.90.92.55 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Containing pantoprazole or its salts | Free | Base MFN | kg |
| 3004.90.92.56 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Containing ondansetron or its salts | Free | Base MFN | kg |
| 3004.90.92.57 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Containing glycopyrrolate or its salts | Free | Base MFN | kg |
| 3004.90.92.58 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Containing loperamide or its salts | Free | Base MFN | kg |
| 3004.90.92.60 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the digestive system: Other | Free | Base MFN | kg |
| 3004.90.92.61 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Diuretics: Containing furosemide and its salts | Free | Base MFN | kg |
| 3004.90.92.62 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Diuretics: Containing hydrochlorothiazide or its salts | Free | Base MFN | kg |
| 3004.90.92.63 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Diuretics: Other | Free | Base MFN | kg |
| 3004.90.92.64 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Other: Containing calcium gluconate | Free | Base MFN | kg |
| 3004.90.92.65 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Other: Containing potassium chloride | Free | Base MFN | kg |
| 3004.90.92.66 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Other: Containing sodium bicarbonate, in injection form | Free | Base MFN | kg |
| 3004.90.92.67 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Preparations primarily affecting the electrolytic, caloric or water balance: Other: Other | Free | Base MFN | kg |
| 3004.90.92.68 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Cough and cold preparations | Free | Base MFN | kg |
| 3004.90.92.69 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Antihistamines: Containing diphenhydramine or its salts | Free | Base MFN | kg |
| 3004.90.92.70 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Antihistamines: Other | Free | Base MFN | kg |
| 3004.90.92.71 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Containing albuterol sulfate | Free | Base MFN | kg |
| 3004.90.92.72 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Other: Containing timolol maleate | Free | Base MFN | kg |
| 3004.90.92.73 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Other: Other | Free | Base MFN | kg |
| 3004.90.92.74 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Other: Containing heparin sodium or its salts | Free | Base MFN | kg |
| 3004.90.92.75 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Other: Containing zoledronic acid or its salts | Free | Base MFN | kg |
| 3004.90.92.76 | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: Other: Other Other: Other: Other | Free | Base MFN | kg |
MODULE 12: Candidate Subheadings & Related Codes
| Related HS Code | Heading Category | Action |
|---|---|---|
| 3004.10 | Subheading under Heading 3004 | HS 3004.10 undefined Duty & Entry Rules → |
| 3004.20 | Subheading under Heading 3004 | HS 3004.20 undefined Duty & Entry Rules → |
| 3004.31 | Subheading under Heading 3004 | HS 3004.31 undefined Duty & Entry Rules → |
| 3004.32 | Subheading under Heading 3004 | HS 3004.32 undefined Duty & Entry Rules → |
MODULE 13: Industry Classification & Crosswalk Mesh (NAICS & Schedule B)
U.S. Census NAICS Code
U.S. Census Schedule B (Exports)
Official Primary Sources & Authority References
USITC HTS Chapter 30 Tariff Schedule (2026) ↗
Official U.S. 10-digit tariff lines and general duty rates for Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other.
CBP CROSS Ruling Database (3004.90) ↗
Binding customs classification precedents for Heading 3004.
MODULE 14: Frequently Asked Questions (FAQ) & Operational Guide
What is the 6-digit WCO tariff classification and United States (USITC HTS) general duty for Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other?
Under WCO Harmonized System 2022 and United States (USITC HTS), Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other is classified under HS 3004.90 (Heading 3004, Chapter 30). The representative US MFN general duty rate is Free.
How is HS 3004.90 distinguished within Heading 3004 (Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale)?
Heading 3004 covers Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. Subheading 3004.90 specifically isolates Other. Importers must verify whether physical characteristics, processing state, or composition require alternative subheadings under Heading 3004.
What are the primary candidate subheadings related to HS 3004.90?
Related subheadings under Heading 3004 include 3004.10, 3004.20, 3004.31, 3004.32, 3004.39, 3004.41, 3004.42, 3004.43. Classification depends on processing stage, decaffeination, purity, or material form.
What mandatory commercial entry documents are required to import Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other?
Commercial Invoice (detailing Incoterms, currency, and origin), Packing List, Bill of Lading (or Air Waybill), CBP Form 7501 Entry Summary, and a continuous customs bond are required for formal entries.
Can goods under HS 3004.90 enter duty-free under USMCA or Free Trade Agreements?
Yes. Eligible goods originating in Mexico, Canada, South Korea, or Australia enter duty-free under preference SPI codes (P, KR, AU) provided they satisfy Regional Value Content (RVC) or tariff-shift rules with a valid Certificate of Origin.
What is the US formal entry threshold for shipments of Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other?
Commercial shipments of Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other with a customs value exceeding $2,500 USD require formal customs entry (CBP Form 7501) and a continuous entry bond. Informal entry applies to lower values.
How can an importer obtain a binding CBP classification ruling for HS 3004.90?
Importers may submit an e-Ruling request under 19 CFR Part 177 to CBP National Commodity Specialist Division (NCSD) to obtain a legally binding tariff classification ruling prior to importation.
What U.S. Census NAICS industry code corresponds to HS 3004.90?
HS 3004.90 maps to NAICS code 325412 (Pharmaceutical and Medicine Manufacturing) under official U.S. Census Bureau trade concordance tables.
Does the United States assess federal VAT or GST on imports of HS 3004.90?
No. The United States does NOT charge a federal Value-Added Tax (VAT) or Goods and Services Tax (GST) on imports. Importers pay customs duty + MPF + HMF (if ocean freight).
How are Merchandise Processing Fee (MPF) and Harbor Maintenance Fee (HMF) calculated?
MPF is assessed at 0.3464% of entered value (min $32.71, max $634.62 per entry). HMF is assessed at 0.125% on ocean freight shipments entering US ports.
What is the Section 321 de minimis duty-free threshold for HS 3004.90?
Under Section 321 (19 U.S.C. 1321), eligible shipments valued at $800 USD or less imported by one person on one day enter duty-free and tax-free.
What U.S. Customs bond requirements apply to commercial entries under HS 3004.90?
Formal entries with customs value exceeding $2,500 USD require a continuous customs entry bond (CBP Form 301) to guarantee payment of duties, taxes, and fees.
What Importer Security Filing (ISF 10+2) rules apply to ocean imports of HS 3004.90?
Ocean container shipments bound for US ports require electronic ISF 10+2 submission via ACE at least 24 hours before loading at foreign ports.
How do USMCA preference rules apply to commercial imports under HS 3004.90?
Qualifying originating goods from Canada or Mexico meeting USMCA tariff-shift or Regional Value Content (RVC) rules enter duty-free under SPI code 'P'.
💬
Ask Jack — Customs Lookup